REGENXBIO Inc
The role leads the development and execution of integrated rare disease brand plans, translating market research into actionable strategies and managing promotional materials and agency partnerships. It also oversees budget, cross‑functional collaboration, and senior stakeholder communication while supporting launch readiness and lifecycle activities.
Headquarters
Rockville, Maryland, United States
Company Size
201-500 employees
Founded
2008
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for REGENXBIO Inc.
REGENXBIO Inc didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role